SS Innovations International, Inc. (NASDAQ: SSII) Stock Competitors & Peer Comparison
See SSII's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SSII and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SSII | $2.87 | -2.71% | 578.4M | -48.17 | -$0.06 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.32 | -0.96% | 174.7B | 19.38 | $5.21 | +2.46% |
| MDT | $88.67 | +0.03% | 114.5B | 16.18 | $5.53 | +3.22% |
| SYK | $277.40 | +1.85% | 105.6B | 20.57 | $13.39 | +1.27% |
| BSX | $43.75 | -0.39% | 65.6B | 14.23 | $3.10 | N/A |
| EW | $86.55 | +0.30% | 50B | 32.16 | $2.70 | N/A |
| DXCM | $86.22 | -0.46% | 32.7B | 33.99 | $2.55 | N/A |
| GEHC | $66.48 | -0.23% | 30.2B | 14.64 | $4.56 | +0.21% |
| PHG | $24.69 | -1.08% | 24.5B | 14.35 | $1.75 | +3.94% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
SSII vs BSX-PA Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, SSII's ROE is -0.27%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, SSII is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
SSII vs ABT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ABT has a market cap of 174.7B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ABT trades at $100.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ABT's P/E ratio is 19.38. In terms of profitability, SSII's ROE is -0.27%, compared to ABT's ROE of +0.11%. Regarding short-term risk, SSII is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ABT's competition here
Medtronic plc (NYSE: MDT)
SSII vs MDT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, MDT has a market cap of 114.5B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while MDT trades at $88.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas MDT's P/E ratio is 16.18. In terms of profitability, SSII's ROE is -0.27%, compared to MDT's ROE of +0.11%. Regarding short-term risk, SSII is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for SSII.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
SSII vs SYK Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SYK has a market cap of 105.6B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SYK trades at $277.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SYK's P/E ratio is 20.57. In terms of profitability, SSII's ROE is -0.27%, compared to SYK's ROE of +0.16%. Regarding short-term risk, SSII is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for SSII.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
SSII vs BSX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BSX has a market cap of 65.6B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BSX trades at $43.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BSX's P/E ratio is 14.23. In terms of profitability, SSII's ROE is -0.27%, compared to BSX's ROE of +0.15%. Regarding short-term risk, SSII is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
SSII vs EW Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, EW has a market cap of 50B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while EW trades at $86.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas EW's P/E ratio is 32.16. In terms of profitability, SSII's ROE is -0.27%, compared to EW's ROE of +0.10%. Regarding short-term risk, SSII is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for SSII.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
SSII vs DXCM Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while DXCM trades at $86.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas DXCM's P/E ratio is 33.99. In terms of profitability, SSII's ROE is -0.27%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, SSII is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for SSII.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
SSII vs GEHC Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, GEHC has a market cap of 30.2B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while GEHC trades at $66.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas GEHC's P/E ratio is 14.64. In terms of profitability, SSII's ROE is -0.27%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SSII is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for SSII.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
SSII vs PHG Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, PHG has a market cap of 24.5B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while PHG trades at $24.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas PHG's P/E ratio is 14.35. In terms of profitability, SSII's ROE is -0.27%, compared to PHG's ROE of +0.10%. Regarding short-term risk, SSII is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for SSII.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
SSII vs ZBH Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ZBH has a market cap of 17.7B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ZBH trades at $91.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ZBH's P/E ratio is 10.80. In terms of profitability, SSII's ROE is -0.27%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, SSII is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
SSII vs ABMD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ABMD's P/E ratio is 65.36. In terms of profitability, SSII's ROE is -0.27%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, SSII is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for SSII.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
SSII vs PEN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while PEN trades at $318.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas PEN's P/E ratio is 83.31. In terms of profitability, SSII's ROE is -0.27%, compared to PEN's ROE of +0.11%. Regarding short-term risk, SSII is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for SSII.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
SSII vs SWAV Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SWAV's P/E ratio is 78.76. In terms of profitability, SSII's ROE is -0.27%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, SSII is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for SSII.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
SSII vs SNN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SNN has a market cap of 11.4B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SNN trades at $26.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SNN's P/E ratio is 18.28. In terms of profitability, SSII's ROE is -0.27%, compared to SNN's ROE of +0.12%. Regarding short-term risk, SSII is similarly volatile compared to SNN. This indicates similar risk in terms of short-term price fluctuations for SSII.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
SSII vs BIO-B Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, SSII's ROE is -0.27%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, SSII is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for SSII.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
SSII vs ALGN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ALGN has a market cap of 10.4B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ALGN trades at $144.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ALGN's P/E ratio is 13.22. In terms of profitability, SSII's ROE is -0.27%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, SSII is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
SSII vs BIO Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BIO trades at $379.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BIO's P/E ratio is 40.70. In terms of profitability, SSII's ROE is -0.27%, compared to BIO's ROE of +0.03%. Regarding short-term risk, SSII is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
SSII vs GMED Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, GMED has a market cap of 10.1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while GMED trades at $74.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas GMED's P/E ratio is 16.84. In terms of profitability, SSII's ROE is -0.27%, compared to GMED's ROE of +0.12%. Regarding short-term risk, SSII is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for SSII.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
SSII vs BRKR Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BRKR has a market cap of 9.6B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BRKR trades at $64.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BRKR's P/E ratio is 31.80. In terms of profitability, SSII's ROE is -0.27%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, SSII is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BRKR's competition here
Masimo Corporation (NASDAQ: MASI)
SSII vs MASI Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas MASI's P/E ratio is 44.43. In terms of profitability, SSII's ROE is -0.27%, compared to MASI's ROE of +0.09%. Regarding short-term risk, SSII is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for SSII.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
SSII vs GKOS Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, GKOS has a market cap of 9.3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while GKOS trades at $157.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas GKOS's P/E ratio is -184.31. In terms of profitability, SSII's ROE is -0.27%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, SSII is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for SSII.Check GKOS's competition here
Bruker Corporation (NASDAQ: BRKRP)
SSII vs BRKRP Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BRKRP has a market cap of 9.3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BRKRP trades at $474.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BRKRP's P/E ratio is 251.76. In terms of profitability, SSII's ROE is -0.27%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, SSII is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BRKRP's competition here
Insulet Corp. (NASDAQ: PODD)
SSII vs PODD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, PODD has a market cap of 9.2B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while PODD trades at $132.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas PODD's P/E ratio is 22.68. In terms of profitability, SSII's ROE is -0.27%, compared to PODD's ROE of +0.27%. Regarding short-term risk, SSII is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for SSII.Check PODD's competition here
Haemonetics Corporation (NYSE: HAE)
SSII vs HAE Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while HAE trades at $106.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas HAE's P/E ratio is 21.13. In terms of profitability, SSII's ROE is -0.27%, compared to HAE's ROE of +0.11%. Regarding short-term risk, SSII is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for SSII.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
SSII vs NARI Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas NARI's P/E ratio is -59.24. In terms of profitability, SSII's ROE is -0.27%, compared to NARI's ROE of -0.00%. Regarding short-term risk, SSII is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for SSII.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
SSII vs ITGR Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ITGR trades at $126.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ITGR's P/E ratio is 19.90. In terms of profitability, SSII's ROE is -0.27%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, SSII is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for SSII.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
SSII vs LIVN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while LIVN trades at $76.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas LIVN's P/E ratio is 18.34. In terms of profitability, SSII's ROE is -0.27%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, SSII is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for SSII.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
SSII vs IRTC Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, IRTC has a market cap of 3.7B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while IRTC trades at $114.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas IRTC's P/E ratio is -261.86. In terms of profitability, SSII's ROE is -0.27%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, SSII is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for SSII.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
SSII vs AXNX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas AXNX's P/E ratio is -709.80. In terms of profitability, SSII's ROE is -0.27%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, SSII is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for SSII.Check AXNX's competition here
Neogen Corporation (NASDAQ: NEOG)
SSII vs NEOG Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while NEOG trades at $13.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas NEOG's P/E ratio is 49.00. In terms of profitability, SSII's ROE is -0.27%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, SSII is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for SSII.Check NEOG's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
SSII vs TMDX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while TMDX trades at $82.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas TMDX's P/E ratio is 41.99. In terms of profitability, SSII's ROE is -0.27%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, SSII is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for SSII.Check TMDX's competition here
Butterfly Network, Inc. (NYSE: BFLY)
SSII vs BFLY Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BFLY trades at $9.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BFLY's P/E ratio is -38.10. In terms of profitability, SSII's ROE is -0.27%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, SSII is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
SSII vs AXGN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while AXGN trades at $43.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas AXGN's P/E ratio is 114.11. In terms of profitability, SSII's ROE is -0.27%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, SSII is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for SSII.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
SSII vs UFPT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while UFPT trades at $300.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas UFPT's P/E ratio is 30.56. In terms of profitability, SSII's ROE is -0.27%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, SSII is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for SSII.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
SSII vs NUVA Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas NUVA's P/E ratio is 75.00. In terms of profitability, SSII's ROE is -0.27%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, SSII is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for SSII.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
SSII vs INSP Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while INSP trades at $70.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas INSP's P/E ratio is 30.84. In terms of profitability, SSII's ROE is -0.27%, compared to INSP's ROE of +0.18%. Regarding short-term risk, SSII is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for SSII.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
SSII vs ESTA Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ESTA trades at $65.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ESTA's P/E ratio is -51.86. In terms of profitability, SSII's ROE is -0.27%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, SSII is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
SSII vs NVCR Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while NVCR trades at $15.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas NVCR's P/E ratio is -12.18. In terms of profitability, SSII's ROE is -0.27%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, SSII is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for SSII.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
SSII vs ATEC Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ATEC trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ATEC's P/E ratio is -167.50. In terms of profitability, SSII's ROE is -0.27%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, SSII is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
SSII vs CNMD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CNMD trades at $46.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CNMD's P/E ratio is 10.20. In terms of profitability, SSII's ROE is -0.27%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, SSII is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for SSII.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
SSII vs HSKA Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas HSKA's P/E ratio is -62.49. In terms of profitability, SSII's ROE is -0.27%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, SSII is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for SSII.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
SSII vs IART Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while IART trades at $16.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas IART's P/E ratio is 6.89. In terms of profitability, SSII's ROE is -0.27%, compared to IART's ROE of -0.01%. Regarding short-term risk, SSII is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for SSII.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
SSII vs AVNS Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas AVNS's P/E ratio is 27.77. In terms of profitability, SSII's ROE is -0.27%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, SSII is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for SSII.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
SSII vs TNDM Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while TNDM trades at $16.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas TNDM's P/E ratio is -17.66. In terms of profitability, SSII's ROE is -0.27%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, SSII is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for SSII.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
SSII vs SILK Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SILK's P/E ratio is -18.96. In terms of profitability, SSII's ROE is -0.27%, compared to SILK's ROE of -0.35%. Regarding short-term risk, SSII is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for SSII.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
SSII vs AORT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while AORT trades at $22.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas AORT's P/E ratio is 38.23. In terms of profitability, SSII's ROE is -0.27%, compared to AORT's ROE of -0.01%. Regarding short-term risk, SSII is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for SSII.Check AORT's competition here
IRadimed Corporation (NASDAQ: IRMD)
SSII vs IRMD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while IRMD trades at $86.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas IRMD's P/E ratio is 43.55. In terms of profitability, SSII's ROE is -0.27%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, SSII is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for SSII.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
SSII vs FNA Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas FNA's P/E ratio is -19.83. In terms of profitability, SSII's ROE is -0.27%, compared to FNA's ROE of -0.35%. Regarding short-term risk, SSII is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for SSII.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
SSII vs ENOV Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ENOV trades at $18.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ENOV's P/E ratio is 5.20. In terms of profitability, SSII's ROE is -0.27%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, SSII is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
SSII vs PRCT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, PRCT has a market cap of 981.9M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while PRCT trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas PRCT's P/E ratio is -8.89. In terms of profitability, SSII's ROE is -0.27%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, SSII is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for SSII.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
SSII vs LMRI Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, LMRI has a market cap of 974.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while LMRI trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas LMRI's P/E ratio is -19.74. In terms of profitability, SSII's ROE is -0.27%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, SSII is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for SSII.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
SSII vs BVS Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BVS has a market cap of 949.8M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BVS trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BVS's P/E ratio is 18.45. In terms of profitability, SSII's ROE is -0.27%, compared to BVS's ROE of +0.28%. Regarding short-term risk, SSII is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
SSII vs CBLL Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CBLL has a market cap of 930M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CBLL trades at $24.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CBLL's P/E ratio is -13.93. In terms of profitability, SSII's ROE is -0.27%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, SSII is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for SSII.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
SSII vs BBNX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BBNX has a market cap of 923.2M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BBNX trades at $20.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BBNX's P/E ratio is -12.44. In terms of profitability, SSII's ROE is -0.27%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, SSII is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BBNX's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
SSII vs CSII Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CSII's P/E ratio is -20.83. In terms of profitability, SSII's ROE is -0.27%, compared to CSII's ROE of -0.14%. Regarding short-term risk, SSII is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for SSII.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
SSII vs SIBN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SIBN has a market cap of 832M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SIBN trades at $18.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SIBN's P/E ratio is -55.18. In terms of profitability, SSII's ROE is -0.27%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, SSII is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for SSII.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
SSII vs INMD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, INMD has a market cap of 816.5M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while INMD trades at $14.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas INMD's P/E ratio is 9.86. In terms of profitability, SSII's ROE is -0.27%, compared to INMD's ROE of +0.12%. Regarding short-term risk, SSII is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for SSII.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
SSII vs VREX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, VREX has a market cap of 777.2M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas VREX's P/E ratio is 19.43. In terms of profitability, SSII's ROE is -0.27%, compared to VREX's ROE of +0.05%. Regarding short-term risk, SSII is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for SSII.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
SSII vs AHCO Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, AHCO has a market cap of 768.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while AHCO trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas AHCO's P/E ratio is 11.53. In terms of profitability, SSII's ROE is -0.27%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, SSII is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for SSII.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
SSII vs AVR Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, AVR has a market cap of 752.6M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while AVR trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas AVR's P/E ratio is -3.99. In terms of profitability, SSII's ROE is -0.27%, compared to AVR's ROE of -0.78%. Regarding short-term risk, SSII is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for SSII.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
SSII vs CTKB Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CTKB has a market cap of 741.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CTKB trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CTKB's P/E ratio is -30.41. In terms of profitability, SSII's ROE is -0.27%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, SSII is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for SSII.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
SSII vs SRDX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SRDX's P/E ratio is -34.66. In terms of profitability, SSII's ROE is -0.27%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, SSII is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for SSII.Check SRDX's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
SSII vs KIDS Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, KIDS has a market cap of 580M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while KIDS trades at $22.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas KIDS's P/E ratio is -19.14. In terms of profitability, SSII's ROE is -0.27%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, SSII is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for SSII.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
SSII vs APEN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas APEN's P/E ratio is -9.43. In terms of profitability, SSII's ROE is -0.27%, compared to APEN's ROE of -0.85%. Regarding short-term risk, SSII is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for SSII.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
SSII vs DCTH Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, DCTH has a market cap of 545.8M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while DCTH trades at $15.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas DCTH's P/E ratio is 1581.00. In terms of profitability, SSII's ROE is -0.27%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, SSII is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for SSII.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
SSII vs ZIMV Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, SSII's ROE is -0.27%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, SSII is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for SSII.Check ZIMV's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
SSII vs PACB Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, PACB has a market cap of 531.1M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while PACB trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas PACB's P/E ratio is -4.17. In terms of profitability, SSII's ROE is -0.27%, compared to PACB's ROE of -49.62%. Regarding short-term risk, SSII is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for SSII.Check PACB's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
SSII vs TCMD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, TCMD has a market cap of 514.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while TCMD trades at $22.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas TCMD's P/E ratio is 21.13. In terms of profitability, SSII's ROE is -0.27%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, SSII is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for SSII.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
SSII vs SGHT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SGHT has a market cap of 504.4M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SGHT trades at $9.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SGHT's P/E ratio is -16.55. In terms of profitability, SSII's ROE is -0.27%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, SSII is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for SSII.Check SGHT's competition here
Cerus Corporation (NASDAQ: CERS)
SSII vs CERS Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CERS has a market cap of 493.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CERS trades at $2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CERS's P/E ratio is -81.40. In terms of profitability, SSII's ROE is -0.27%, compared to CERS's ROE of -0.10%. Regarding short-term risk, SSII is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for SSII.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
SSII vs NPCE Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, NPCE has a market cap of 482.4M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while NPCE trades at $14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas NPCE's P/E ratio is -24.82. In terms of profitability, SSII's ROE is -0.27%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, SSII is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for SSII.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
SSII vs CLPT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CLPT has a market cap of 459.1M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CLPT trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CLPT's P/E ratio is -12.97. In terms of profitability, SSII's ROE is -0.27%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, SSII is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for SSII.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
SSII vs SENS Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SENS has a market cap of 411.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SENS trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SENS's P/E ratio is -4.41. In terms of profitability, SSII's ROE is -0.27%, compared to SENS's ROE of -1.66%. Regarding short-term risk, SSII is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for SSII.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
SSII vs OFIX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, OFIX has a market cap of 397.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while OFIX trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas OFIX's P/E ratio is -6.41. In terms of profitability, SSII's ROE is -0.27%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, SSII is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for SSII.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
SSII vs CV Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CV has a market cap of 345.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CV trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CV's P/E ratio is -10.98. In terms of profitability, SSII's ROE is -0.27%, compared to CV's ROE of -1.78%. Regarding short-term risk, SSII is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for SSII.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
SSII vs SMLR Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas SMLR's P/E ratio is 3.92. In terms of profitability, SSII's ROE is -0.27%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, SSII is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for SSII.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
SSII vs TMCI Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, TMCI has a market cap of 290.6M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while TMCI trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas TMCI's P/E ratio is -4.77. In terms of profitability, SSII's ROE is -0.27%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, SSII is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for SSII.Check TMCI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
SSII vs RCEL Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, RCEL has a market cap of 289.9M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while RCEL trades at $11.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas RCEL's P/E ratio is -8.10. In terms of profitability, SSII's ROE is -0.27%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, SSII is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for SSII.Check RCEL's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
SSII vs CATX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, CATX has a market cap of 286.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while CATX trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas CATX's P/E ratio is -1.89. In terms of profitability, SSII's ROE is -0.27%, compared to CATX's ROE of -0.42%. Regarding short-term risk, SSII is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for SSII.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
SSII vs TLSI Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, TLSI has a market cap of 270.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while TLSI trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas TLSI's P/E ratio is -2.61. In terms of profitability, SSII's ROE is -0.27%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, SSII is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for SSII.Check TLSI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
SSII vs INFU Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, INFU has a market cap of 259.4M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while INFU trades at $12.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas INFU's P/E ratio is 31.35. In terms of profitability, SSII's ROE is -0.27%, compared to INFU's ROE of +0.15%. Regarding short-term risk, SSII is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for SSII.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
SSII vs MGRM Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas MGRM's P/E ratio is -12.00. In terms of profitability, SSII's ROE is -0.27%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, SSII is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for SSII.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
SSII vs ELMD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ELMD has a market cap of 233.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ELMD trades at $27.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ELMD's P/E ratio is 21.51. In terms of profitability, SSII's ROE is -0.27%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, SSII is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
SSII vs NVRO Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas NVRO's P/E ratio is -1.91. In terms of profitability, SSII's ROE is -0.27%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, SSII is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for SSII.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
SSII vs PROF Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, PROF has a market cap of 215.1M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while PROF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas PROF's P/E ratio is -6.04. In terms of profitability, SSII's ROE is -0.27%, compared to PROF's ROE of -0.56%. Regarding short-term risk, SSII is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for SSII.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
SSII vs RXST Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, RXST has a market cap of 193.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while RXST trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas RXST's P/E ratio is -4.13. In terms of profitability, SSII's ROE is -0.27%, compared to RXST's ROE of -0.17%. Regarding short-term risk, SSII is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for SSII.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
SSII vs BSGM Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas BSGM's P/E ratio is -5.81. In terms of profitability, SSII's ROE is -0.27%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, SSII is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for SSII.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
SSII vs MDGS Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas MDGS's P/E ratio is -0.27. In terms of profitability, SSII's ROE is -0.27%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, SSII is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for SSII.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
SSII vs STIM Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, STIM has a market cap of 177.8M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while STIM trades at $2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas STIM's P/E ratio is -5.81. In terms of profitability, SSII's ROE is -0.27%, compared to STIM's ROE of -1.51%. Regarding short-term risk, SSII is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for SSII.Check STIM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
SSII vs FOCL Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, FOCL has a market cap of 169.8M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while FOCL trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas FOCL's P/E ratio is -4.38. In terms of profitability, SSII's ROE is -0.27%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, SSII is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for SSII.Check FOCL's competition here
Quanterix Corporation (NASDAQ: QTRX)
SSII vs QTRX Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, QTRX has a market cap of 165.8M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while QTRX trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas QTRX's P/E ratio is -1.39. In terms of profitability, SSII's ROE is -0.27%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, SSII is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for SSII.Check QTRX's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
SSII vs QIPT Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas QIPT's P/E ratio is -15.87. In terms of profitability, SSII's ROE is -0.27%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, SSII is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for SSII.Check QIPT's competition here
Quantum-Si incorporated (NASDAQ: QSI)
SSII vs QSI Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, QSI has a market cap of 157.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while QSI trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas QSI's P/E ratio is -1.73. In terms of profitability, SSII's ROE is -0.27%, compared to QSI's ROE of -0.47%. Regarding short-term risk, SSII is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for SSII.Check QSI's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
SSII vs LUCD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, LUCD has a market cap of 153.7M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while LUCD trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas LUCD's P/E ratio is -2.18. In terms of profitability, SSII's ROE is -0.27%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, SSII is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for SSII.Check LUCD's competition here
Inogen, Inc. (NASDAQ: INGN)
SSII vs INGN Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, INGN has a market cap of 147.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while INGN trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas INGN's P/E ratio is -5.98. In terms of profitability, SSII's ROE is -0.27%, compared to INGN's ROE of -0.13%. Regarding short-term risk, SSII is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for SSII.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
SSII vs ICAD Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ICAD's P/E ratio is -20.37. In terms of profitability, SSII's ROE is -0.27%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, SSII is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for SSII.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
SSII vs ECOR Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ECOR has a market cap of 99.4M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ECOR trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ECOR's P/E ratio is -6.57. In terms of profitability, SSII's ROE is -0.27%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, SSII is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
SSII vs HJLI Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas HJLI's P/E ratio is N/A. In terms of profitability, SSII's ROE is -0.27%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, SSII is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for SSII.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
SSII vs ASXC Comparison September 2026
SS Innovations International, Inc. (NASDAQ: SSII) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 578.4M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, SSII is priced at $2.87 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -48.17, whereas ASXC's P/E ratio is -1.12. In terms of profitability, SSII's ROE is -0.27%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, SSII is less volatile compared to ASXC. This indicates lower risk in terms of short-term price fluctuations for SSII.Check ASXC's competition here